448 related articles for article (PubMed ID: 21148021)
1. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.
Halberstadt AL; Koedood L; Powell SB; Geyer MA
J Psychopharmacol; 2011 Nov; 25(11):1548-61. PubMed ID: 21148021
[TBL] [Abstract][Full Text] [Related]
2. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors.
Riga MS; Bortolozzi A; Campa L; Artigas F; Celada P
Neuropharmacology; 2016 Feb; 101():370-8. PubMed ID: 26477571
[TBL] [Abstract][Full Text] [Related]
3. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT
Riga MS; Lladó-Pelfort L; Artigas F; Celada P
Neuropharmacology; 2018 Nov; 142():219-230. PubMed ID: 29221792
[TBL] [Abstract][Full Text] [Related]
4. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.
Krebs-Thomson K; Ruiz EM; Masten V; Buell M; Geyer MA
Psychopharmacology (Berl); 2006 Dec; 189(3):319-29. PubMed ID: 17013638
[TBL] [Abstract][Full Text] [Related]
5. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
[TBL] [Abstract][Full Text] [Related]
6. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
[TBL] [Abstract][Full Text] [Related]
7. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
Halberstadt AL; Buell MR; Masten VL; Risbrough VB; Geyer MA
Psychopharmacology (Berl); 2008 Nov; 201(1):55-66. PubMed ID: 18604652
[TBL] [Abstract][Full Text] [Related]
8. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
[TBL] [Abstract][Full Text] [Related]
9. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB
Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172
[TBL] [Abstract][Full Text] [Related]
10. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.
van den Buuse M; Ruimschotel E; Martin S; Risbrough VB; Halberstadt AL
Neuropharmacology; 2011; 61(1-2):209-16. PubMed ID: 21501627
[TBL] [Abstract][Full Text] [Related]
11. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 5-HT
Erkizia-Santamaría I; Alles-Pascual R; Horrillo I; Meana JJ; Ortega JE
Biomed Pharmacother; 2022 Oct; 154():113612. PubMed ID: 36049313
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
Halberstadt AL
Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
[TBL] [Abstract][Full Text] [Related]
14. Psilocybin-induced stimulus control in the rat.
Winter JC; Rice KC; Amorosi DJ; Rabin RA
Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
[TBL] [Abstract][Full Text] [Related]
15. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
[TBL] [Abstract][Full Text] [Related]
16. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.
Quednow BB; Kometer M; Geyer MA; Vollenweider FX
Neuropsychopharmacology; 2012 Feb; 37(3):630-40. PubMed ID: 21956447
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor.
Halberstadt AL; Nichols DE; Geyer MA
Psychopharmacology (Berl); 2012 Jun; 221(4):709-18. PubMed ID: 22222861
[TBL] [Abstract][Full Text] [Related]
18. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.
Halberstadt AL; Geyer MA
Neuropharmacology; 2014 Feb; 77():200-7. PubMed ID: 24012658
[TBL] [Abstract][Full Text] [Related]
19. Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.
Jiang XL; Shen HW; Yu AM
Pharmacol Rep; 2016 Jun; 68(3):608-15. PubMed ID: 26977821
[TBL] [Abstract][Full Text] [Related]
20. Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.
Tylš F; Páleníček T; Kadeřábek L; Lipski M; Kubešová A; Horáček J
Behav Pharmacol; 2016 Jun; 27(4):309-20. PubMed ID: 26461483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
